Probiotics for Human and Poultry Use in the Control of Gastrointestinal Disease: A Review of Real-World Experiences

Téllez, G.; Rodríguez‐Fragoso, Lourdes; Va, Kuttappan; Kallapura, G.; Xh, Velasco; Menconi, A.; Latorre, Juan D.; Ad, Wolfenden; Bm, Hargis; Reyes‐Esparza, Jorge

doi:10.4172/2327-5162.1000118

Cited by 4 publications

(1 citation statement)

References 100 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several studies have reported different to prevent infections against foodborne pathogens [25,26,45]. In this report, we showed that L. t inflammatory foci at 4F and 4H).…”

Section: Discussionsupporting

confidence: 52%

Lactobacillus rhamnosus V5 Prevents Salmonella enterica Serovar Typhimurium Invasion in Cell Culture and Mice Infection

Tsuruda

Souza

Nishio

et al. 2020

MRJI

View full text Add to dashboard Cite

Aims: The aim of this study was to evaluate the protective capacity of the exopolysaccharide-producing Lactobacillus rhamnosus V5 against invasion in vitro and in vivo with S. typhimurium. Methodology: We tested the antimicrobial activity of the compound extracted from the lactobacilli against S. typhimurium directly, also we tested the interference of this compound in S. typhimurium adherence and invasion of HeLa and HEp-2 cells (in vitro testings). For in vivo experiments, we used 16 BALB/c female mice. Through gavage method we introduced L. rhamnosus as probiotic and then infected mice with S. enterica serovar typhimurium. After euthanasia, spleen, liver and Peyer's patches removed for microbiological and histopathological analysis. Results: The results showed that lactobacilli were able to produce antimicrobial compounds against S. typhimurium. These lactobacilli inhibited the adhesion and invasion of S. typhimurium in HeLa and HEp-2 cells, respectively. The challenge assay in the murine model demonstrated a decrease in pathogen translocation in the spleen and liver from mice treated with probiotic as well as protection of ileal tissue in lactobacilli-treated mice. The histopathological analysis demonstrated the presence of prominent lymphoid nodules in the ileum from the non-treated lactobacilli mice. Conclusion: Our results suggest that L. rhamnosus improved the effectiveness of the intestinal barrier and, thus, could be a potential probiotic to control salmonellosis.

show abstract

“…Several studies have reported different to prevent infections against foodborne pathogens [25,26,45]. In this report, we showed that L. t inflammatory foci at 4F and 4H).…”

Section: Discussionsupporting

confidence: 52%

Lactobacillus rhamnosus V5 Prevents Salmonella enterica Serovar Typhimurium Invasion in Cell Culture and Mice Infection

Tsuruda

Souza

Nishio

et al. 2020

MRJI

View full text Add to dashboard Cite

show abstract

Effects of in Ovo Synbiotic Injection on Growth Performance, Intestinal Bacterial Load and Antibody Titres in Broiler Chickens Vaccinated Against Infectious Bursal Disease

Babazadeh

Asasi

2021

BJVM

View full text Add to dashboard Cite

The present study investigated the efficacy of a synbiotic (Lactobacillus delbrueckii subsp. bulgar-icus, Streptococcus salivarius subsp. thermophilus, and mannan oligosaccharide) along with an infectious bursal disease (IBD) vaccine in Cobb 500 broilers. A total of 1200 embryonated chicken eggs were randomly allocated in 10 groups with eight replicates. The first group did not receive any treatment. The second group was vaccinated post-hatch (PV), the third group was vaccinated in ovo (IV), the fourth group received dietary synbiotic and in ovo vaccination (DS+IV), the fifth group was treated in ovo with synbiotic (IS), the sixth group received in ovo and dietary synbiotic (IS+DS), the seventh group received in ovo synbiotic plus post-hatch vaccination (IS+PV) and the eighth group  in ovo and dietary synbiotic and post-hatch vaccination (IS+DS+PV). In the ninth group, the synbiotic and the vaccine were administered in ovo (IS+IV) while the tenth group re-ceived in ovo and dietary synbiotic, plus in ovo vaccine (IS+DS+IV). The in ovo treatment with the synbiotic in combination with DS, IV or PV had a positive effect on weekly weight gain. The sixth group provided a better feed conversion ratio at the end of fourth week. The synbiotic appli-cation, individually in sixth group or along with PV or IV treatment in eighth and tenth groups, elevated feed intake in fifth and sixth weeks respectively.The antibody titre of IBD was higher for groups which received IV along with IS. It is concluded that the application of synbiotic along to IBD vaccine improved growth performance and had positive effects on IBD antibody titres.

show abstract

Recent Advances in Screening of Anti-Campylobacter Activity in Probiotics for Use in Poultry

et al. 2016

View full text Add to dashboard Cite

Campylobacteriosis is the most common cause of bacterial gastroenteritis worldwide. Campylobacter species involved in this infection usually include the thermotolerant species Campylobacter jejuni. The major reservoir for C. jejuni leading to human infections is commercial broiler chickens. Poultry flocks are frequently colonized by C. jejuni without any apparent symptoms. Risk assessment analyses have identified the handling and consumption of poultry meat as one of the most important sources of human campylobacteriosis, so elimination of Campylobacter in the poultry reservoir is a crucial step in the control of this foodborne infection. To date, the use of probiotics has demonstrated promising results to reduce Campylobacter colonization. This review provides recent insights into methods used for probiotic screening to reduce the prevalence and colonization of Campylobacter at the farm level. Different eukaryotic epithelial cell lines are employed to screen probiotics with an anti-Campylobacter activity and yield useful information about the inhibition mechanism involved. These in vitro virulence models involve only human intestinal or cervical cell lines whereas the use of avian cell lines could be a preliminary step to investigate mechanisms of C. jejuni colonization in poultry in the presence of probiotics. In addition, in vivo trials to evaluate the effect of probiotics on Campylobacter colonization are conducted, taking into account the complexity introduced by the host, the feed, and the microbiota. However, the heterogeneity of the protocols used and the short time duration of the experiments lead to results that are difficult to compare and draw conclusions at the slaughter-age of broilers. Nevertheless, the combined approach using complementary in vitro and in vivo tools (cell cultures and animal experiments) leads to a better characterization of probiotic strains and could be employed to assess reduced Campylobacter spp. colonization in chickens if some parameters are optimized.

show abstract

Probiotics for Human and Poultry Use in the Control of Gastrointestinal Disease: A Review of Real-World Experiences

Cited by 4 publications

References 100 publications

Lactobacillus rhamnosus V5 Prevents Salmonella enterica Serovar Typhimurium Invasion in Cell Culture and Mice Infection

Lactobacillus rhamnosus V5 Prevents Salmonella enterica Serovar Typhimurium Invasion in Cell Culture and Mice Infection

Effects of in Ovo Synbiotic Injection on Growth Performance, Intestinal Bacterial Load and Antibody Titres in Broiler Chickens Vaccinated Against Infectious Bursal Disease

Recent Advances in Screening of Anti-Campylobacter Activity in Probiotics for Use in Poultry

Contact Info

Product

Resources

About